What Researchers Did
The researchers conducted a Cochrane Review to systematically evaluate the evidence on hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for patients with necrotizing fasciitis, searching multiple databases up to September 2014.
What They Found
The provided abstract did not report specific findings or numerical data regarding the efficacy or adverse effects of hyperbaric oxygen therapy for necrotizing fasciitis. Therefore, it is not possible to summarize the results from the given text.
What This Means for Canadian Patients
This review aimed to clarify whether hyperbaric oxygen therapy offers benefits in reducing mortality or morbidity for patients with necrotizing fasciitis. If effective, HBOT could potentially improve outcomes for Canadian patients suffering from this severe infection.
Canadian Relevance
There is no specific Canadian connection mentioned in the study metadata or abstract.
Study Limitations
The provided abstract was truncated and did not detail specific study limitations or the quality of the evidence reviewed.